Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionDaniel K. Wells, Elham Sherafat, Kathleen C. F. Sheehan et al.|Cell|2020Cited by 546
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB–D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915Georgina V. Long, Jeffrey S. Weber, Hao Tang et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 11